India’s Biocon developing its own version of Wegovy, clinical trial likely next year
Indian drugmaker Biocon , looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk’s wildly popular Wegovy and is prepared to conduct a clinical trial next year if needed, the CEO told Reuters.